← Back to Patent Explorer
US4064236A Expired / Lapsed US ⏱️ 0.0 years remaining

Peptide carbazates and pharmaceutical composition

Assignee: Merck and Co Inc
•
Filing: 1975-12-23
•
Granted: 1977-12-20
•
Expires: 1995-12-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Certain novel peptide carbazates, their preparation, pharmaceutical compositions and novel methods of treating pancreatitis.

Inventors

  • 👤 Conrad P. Dorn
  • 👤 Shu S. Yang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 10:33
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0821; C07K5/0823; A; A61; A61P; A61P29/00; C07K5/0802; C07K5/0804; C07K5/0806; A61K; A61K38/00

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 105 words
A compound of the formula: ##STR5## wherein B is C 1-5 alkanoyl, t-butoxycarbonyl or carbobenzyloxy, P 4 is alanyl or prolyl, P 3 is alanyl, P 2 is prolyl or leucyl, R 1 is C 1-5 alkyl, R 2 is methyl, benzyl or 4-aminobutyl, and R 3 is hydroxy, C 1-5 Alkoxy, amino, N-C 1-5 alkylamino, N,N-di-(C 1-5 alkyl)amino, N-benzylamino, N-phenylamino, hydrazino, methylhydrazino, ethylhydrazino, phenylhydrazino, benzylhydrazino, benzyloxy, or p-iodobenzyloxy or ##STR6## wherein R 4 is methyl or benzyl, and R 5 is hydroxy, C 1-5 alkoxy, amino, N-C 1-5 alkylamino, N,N-di-(C 1-5 alkyl)amino, N-benzylamino, N-phenylamino, hydrazino, benzyloxy, or p-iodobenzyloxy and Z is -NH- or --0--.
Claim 2
Dependent Claim 105 words
A compound of the formula: ##STR5## wherein B is C 1-5 alkanoyl, t-butoxycarbonyl or carbobenzyloxy, P 4 is alanyl or prolyl, P 3 is alanyl, P 2 is prolyl or leucyl, R 1 is C 1-5 alkyl, R 2 is methyl, benzyl or 4-aminobutyl, and R 3 is hydroxy, C 1-5 Alkoxy, amino, N-C 1-5 alkylamino, N,N-di-(C 1-5 alkyl)amino, N-benzylamino, N-phenylamino, hydrazino, methylhydrazino, ethylhydrazino, phenylhydrazino, benzylhydrazino, benzyloxy, or p-iodobenzyloxy or ##STR6## wherein R 4 is methyl or benzyl, and R 5 is hydroxy, C 1-5 alkoxy, amino, N-C 1-5 alkylamino, N,N-di-(C 1-5 alkyl)amino, N-benzylamino, N-phenylamino, hydrazino, benzyloxy, or p-iodobenzyloxy and Z is -NH- or --0--.
Claim 3
Dependent Claim 40 words
The compound of claim 1 wherein B is C 1-5 alkanoyl, R 1 is methyl or isopropyl, R 2 is methyl or benzyl, and R 3 is C 1-5 alkoxy, benzyloxy, p-iodobenzyloxy, amino, hydrazino, N-phenylamino, N-benzylamino or C 1-5 -alkylamino.
Claim 4
Dependent Claim 33 words
The compound of claim 2 wherein B is acetyl, P 2 is prolyl, R 1 is methyl, R 2 is methyl, and R 3 is benzyloxy, p-iodobenylzoxy, amino, hydrazino, N-phenylamino, N-benzylamino or N-methylamino.
Claim 5
Dependent Claim 14 words
The compound of claim 3 wherein P 4 is alanyl. 5. The compound of
Claim 6
Dependent Claim 11 words
claim 3 wherein P 4 is prolyl. 6. Acetylprolylalanylprolyl-2-azaalanyl-di-lacthydrazide according to
Claim 7
Dependent Claim 6 words
claim 5. 7. Acetylprolylalanylprolyl-2-azaalanyl-di-lactamide according to
Claim 8
Dependent Claim 6 words
claim 5. 8. Acetylalanylalanylprolyl-2-azaalanyl-di-lactamide according to
Claim 9
Dependent Claim 114 words
claim 5. 9. A pharmaceutical composition comprising a non-toxic pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of the formula: ##STR7## wherein B is C 1-5 alkanoyl, t-butoxycarbonyl or carbobenzyloxy, P 4 is alanyl or prolyl, P 3 is alanyl, P 2 is prolyl or leucyl, R 1 is C 1-5 alkyl, R 2 is methyl, benzyl or 4-aminobutyl, and R 3 is hydroxy, C 1-5 alkoxy, amino, N-C 1-5 alkylamino, N-benzylamino, N-phenylamino, hydrazino, methylhydrazino, ethylhydrazino, phenylhydrazino, benzylhydrazino, benzyloxy, or ##STR8## wherein R 4 is methyl or benzyl, and R 5 is hydroxy, C 1-5 alkoxy, amino, N-C 1-5 alkylamino, N-benzylamino, N-phenylamino, hydrazino, benzyloxy, or p-iodobenzyloxy and Z is --NH--or --0--.

References Cited (Backward Citations)

US3888840A Cited
US3904593A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-12-19 1981-06-20 1981-12-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-12-19 1985-06-20 1985-12-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-12-19 1989-06-20 1989-12-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag